Thermo Fisher Scientific Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $9.85B | $4.01B | $8.08B | $8.52B | $4.48B | $10.33B | $2.40B | $2.10B |
| Accounts Receivable | $8.90B | $8.19B | $8.22B | $8.12B | $7.98B | $5.74B | $4.35B | $4.14B |
| Inventory | $5.43B | $4.98B | $5.09B | $5.63B | $5.05B | $4.03B | $3.37B | $3.01B |
| Total Current Assets | $28.71B | $22.14B | $24.59B | $25.23B | $20.11B | $21.96B | $11.89B | $10.63B |
| Property, Plant & Equipment | $10.57B | $9.31B | $9.45B | $9.28B | $8.33B | $5.91B | $4.75B | $4.17B |
| Goodwill | $49.36B | $45.85B | $44.02B | $41.20B | $41.92B | $26.04B | $25.71B | $25.35B |
| Intangible Assets (Excl. Goodwill) | $15.84B | $15.53B | $16.67B | $17.44B | $20.11B | $12.69B | $14.01B | $14.98B |
| Total Assets | $110.34B | $97.32B | $98.73B | $97.15B | $95.12B | $69.05B | $58.38B | $56.23B |
| Liabilities | ||||||||
| Accounts Payable | $3.62B | $3.08B | $2.87B | $3.38B | $2.87B | $2.18B | $1.92B | $1.62B |
| Total Current Liabilities | $15.19B | $13.33B | $14.01B | $17.01B | $13.44B | $10.30B | $6.20B | $6.15B |
| Long-Term Debt | $39.17B | $31.07B | $34.73B | $34.28B | $34.67B | $19.11B | $17.08B | $17.72B |
| Total Liabilities | $56.94B | $47.74B | $51.99B | $53.18B | $54.33B | $34.55B | $28.71B | $28.65B |
| Stockholders' Equity | ||||||||
| Retained Earnings | $59.16B | $53.10B | $47.36B | $41.91B | $35.43B | $28.12B | $22.09B | $18.70B |
| Total Stockholders' Equity | $53.41B | $49.58B | $46.74B | $43.98B | $40.79B | $34.51B | $29.68B | $27.59B |